Niemann–Pick Type C Disease Proteins: Orphan Transporters Or Membrane Rheostats?

Bibliography

• Lee MC, Miller EA, Goldberg J, Orci L, Schekman R: Bi-directional protein transport between the ER and Golgi. Annu. Rev. Cell Dev. Biol. 20, 87–123 (2004).
   Google Scholar
• Higaki K, Almanzar-Paramio D, Sturley SL: Metazoan and microbial models of Niemann–Pick type C disease. Biochim. Biophys. Acta 1685, 38–47 (2004).
   Google Scholar
• Sturley SL, Patterson MC, Balch W, Liscum L: The pathophysiology and mechanisms of NP-C disease. Biochim. Biophys. Acta 1685, 83–87 (2004).
   Google Scholar
• Liscum L, Sturley SL: Intracellular trafficking of Niemann–Pick C proteins 1 and 2: obligate components of subcellular lipid transport. Biochim. Biophys. Acta 1685, 22–27 (2004).
   Google Scholar
• Koudinov AR, Koudinova NV: Cholesterol homeostasis failure as a unifying cause of synaptic degeneration. J. Neurol. Sci. 229–230, 233–240 (2005).
   Google Scholar
• Valenza M, Cattaneo E: Cholesterol dysfunction in neurodegenerative diseases: is Huntington's disease in the list? Prog. Neurobiol. 80, 165–176 (2006).
   Google Scholar
• Pentchev PG: Niemann–Pick C research from mouse to gene. Biochim. Biophys. Acta 1685, 3–7 (2004).
   Google Scholar
• Neufeld EB, Wastney M, Patel S et al.: The Niemann–Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo. J. Biol. Chem. 274, 9627–9635 (1999).
   Google Scholar
• Sun X, Marks DL, Park WD et al.: Niemann–Pick C variant detection by altered sphingolipid trafficking and correlation with mutations within a specific domain of NPC1. Am. J. Hum. Genet. 68, 1361–1372 (2001).
   Google Scholar
• Carstea ED, Morris JA, Coleman KG et al.: Niemann–Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science 277, 228–231 (1997).
   Google Scholar
• Isolation of human Niemann–Pick type C (NPC)1, the gene defective in the majority of patients with NPC disease.
   Google Scholar
• Millard EE, Gale SE, Dudley N, Zhang J, Schaffer JE, Ory DS: The sterol-sensing domain of the Niemann–Pick C1 (NPC1) protein regulates trafficking of low density lipoprotein cholesterol. J. Biol. Chem. 280, 28581–28590 (2005).
   Google Scholar
• Malathi K, Higaki K, Tinkelenberg AH et al.: Mutagenesis of the putative sterol-sensing domain of yeast Niemann Pick C-related protein reveals a primordial role in subcellular sphingolipid distribution. J. Cell Biol. 164, 547–556 (2004).
   Google Scholar
• Dominant mutation in the yeast ortholog elevates sphingolipid metabolism to the status as the primordial metabolite of relevance to NPC disease.
   Google Scholar
• Millat G, Marcais C, Tomasetto C et al.: Niemann–Pick C1 disease: correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop. Am. J. Hum. Genet. 68, 1373–1385 (2001).
   Google Scholar
• Greer WL, Dobson MJ, Girouard GS, Byers DM, Riddell DC, Neumann PE: Mutations in NPC1 highlight a conserved NPC1-specific cysteine-rich domain. Am. J. Hum. Genet. 65, 1252–1260 (1999).
   Google Scholar
• Park WD, O’Brien JF, Lundquist PA et al.: Identification of 58 novel mutations in Niemann–Pick disease type C: correlation with biochemical phenotype and importance of PTC1-like domains in NPC1. Hum. Mutat. 22, 313–325 (2003).
   Google Scholar
• Naureckiene S, Sleat DE, Lackland H et al.: Identification of HE1 as the second gene of Niemann–Pick C disease. Science 290, 2298–2301 (2000).
   Google Scholar
• Isolation of NPC2, the gene defective in the minority of individuals with NPC disease.
   Google Scholar
• Friedland N, Liou HL, Lobel P, Stock AM: Structure of a cholesterol-binding protein deficient in Niemann–Pick type C2 disease. Proc. Natl Acad. Sci. USA 100, 2512–2517 (2003).
   Google Scholar
• Cheruku SR, Xu Z, Dutia R, Lobel P, Storch J: Mechanism of cholesterol transfer from the Niemann–Pick type C2 protein to model membranes supports a role in lysosomal cholesterol transport. J. Biol. Chem. 281, 31594–31604 (2006).
   Google Scholar
• Liou HL, Dixit SS, Xu S, Tint GS, Stock AM, Lobel P: NPC2, the protein deficient in Niemann–Pick C2 disease, consists of multiple glycoforms that bind a variety of sterols. J. Biol. Chem. 281, 36710–36723 (2006).
   Google Scholar
• Schrantz N, Sagiv Y, Liu Y, Savage PB, Bendelac A, Teyton L: The Niemann–Pick type C2 protein loads isoglobotrihexosylceramide onto CD1d molecules and contributes to the thymic selection of NKT cells. J. Exp. Med. 204, 841–852 (2007).
   Google Scholar
• Sleat DE, Wiseman JA, El-Banna M et al.: Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport. Proc. Natl Acad. Sci. USA 101, 5886–5891 (2004).
   Google Scholar
• Davies JP, Chen FW, Ioannou YA: Transmembrane molecular pump activity of Niemann–Pick C1 protein. Science 290, 2295–2298 (2000).
   Google Scholar
• Sequence conservations suggest that NPC1 is a permease.
   Google Scholar
• Scott C, Ioannou YA: The NPC1 protein: structure implies function. Biochim. Biophys. Acta 1685, 8–13 (2004).
   Google Scholar
• Passeggio J, Liscum L: Flux of fatty acids through NPC1 lysosomes. J. Biol. Chem. 280, 10333–10339 (2005).
   Google Scholar
• Chen FW, Gordon RE, Ioannou YA: NPC1 late endosomes contain elevated levels of non-esterified (‘free’) fatty acids and an abnormally glycosylated form of the NPC2 protein. Biochem. J. 390, 549–561 (2005).
   Google Scholar
• Millat G, Chikh K, Naureckiene S et al.: Niemann–Pick disease type C: spectrum of HE1 mutations and genotype/phenotype correlations in the NPC2 group. Am. J. Hum. Genet. 69, 1013–1021 (2001).
   Google Scholar
• Garcia-Calvo M, Lisnock J, Bull HG et al.: The target of ezetimibe is Niemann–Pick C1-Like 1 (NPC1L1). Proc. Natl Acad. Sci. USA 102, 8132–8137 (2005).
   Google Scholar
• Walkley SU, Suzuki K: Consequences of NPC1 and NPC2 loss of function in mammalian neurons. Biochim. Biophys. Acta 1685, 48–62 (2004).
   Google Scholar
• Berger AC, Vanderford TH, Gernert KM, Nichols JW, Faundez V, Corbett AH: Saccharomyces cerevisiae Npc2p is a functionally conserved homologue of the human Niemann–Pick disease type C 2 protein, hNPC2. Eukaryot. Cell 4, 1851–1862 (2005).
   Google Scholar
• Sym M, Basson M, Johnson C: A model for Niemann–Pick type C disease in the nematode Caenorhabditis elegans. Curr. Biol. 10, 527–530 (2000).
   Google Scholar
• Huang X, Suyama K, Buchanan J, Zhu AJ, Scott MP: A Drosophila model of the Niemann–Pick type C lysosome storage disease: dnpc1a is required for molting and sterol homeostasis. Development 132, 5115–5124 (2005).
   Google Scholar
• Fluegel ML, Parker TJ, Pallanck LJ: Mutations of a Drosophila NPC1 gene confer sterol and ecdysone metabolic defects. Genetics 172, 185–196 (2006).
   Google Scholar
• Altmann SW, Davis HR Jr, Zhu LJ et al.: Niemann–Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 303, 1201–1204 (2004).
   Google Scholar
• A paralog of NPC1 is implicated in sterol absorption in humans and mice and as the putative target of ezetimide, an inhibitor of dietary sterol absorption.
   Google Scholar
• Voght SP, Fluegel ML, Andrews LA, Pallanck LJ: Drosophila NPC1b promotes an early step in sterol absorption from the midgut epithelium. Cell Metab. 5, 195–205 (2007).
   Google Scholar
• Zhang S, Ren J, Li H et al.: Ncr1p, the yeast ortholog of mammalian Niemann Pick C1 protein, is dispensable for endocytic transport. Traffic 5, 1017–1030 (2004).
   Google Scholar
• Berger AC, Hanson PK, Wylie Nichols J, Corbett AH: A yeast model system for functional analysis of the Niemann–Pick type C protein 1 homolog, Ncr1p. Traffic 6, 907–917 (2005).
   Google Scholar
• Ohgami N, Ko DC, Thomas M, Scott MP, Chang CC, Chang TY: Binding between the Niemann–Pick C1 protein and a photoactivatable cholesterol analog requires a functional sterol-sensing domain. Proc. Natl Acad. Sci. USA 101, 12473–12478 (2004).
   Google Scholar
• Ko DC, Binkley J, Sidow A, Scott MP: The integrity of a cholesterol-binding pocket in Niemann–Pick C2 protein is necessary to control lysosome cholesterol levels. Proc. Natl Acad. Sci. USA 100, 2518–2525 (2003).
   Google Scholar
• Patterson MC, Di Bisceglie AM, Higgins JJ et al.: The effect of cholesterol-lowering agents on hepatic and plasma cholesterol in Niemann–Pick disease type C. Neurology 43, 61–64 (1993).
   Google Scholar
• Somers KL, Wenger DA, Royals MA et al.: Complementation studies in human and feline Niemann–Pick type C disease. Mol. Genet. Metab. 66, 117–121 (1999).
   Google Scholar
• Hsu YS, Hwu WL, Huang SF et al.: Niemann–Pick disease type C (a cellular cholesterol lipidosis) treated by bone marrow transplantation. Bone Marrow Transplant. 24, 103–107 (1999).
   Google Scholar
• Xie C, Burns DK, Turley SD, Dietschy JM: Cholesterol is sequestered in the brains of mice with Niemann–Pick type C disease but turnover is increased. J. Neuropathol. Exp. Neurol. 59, 1106–1117 (2000).
   Google Scholar
• Zervas M, Somers KL, Thrall MA, Walkley SU: Critical role for glycosphingolipids in Niemann–Pick disease type C. Curr. Biol. 11, 1283–1287 (2001).
   Google Scholar
• Inhibition of ganglioside biosynthesis ameliorates disease symptoms and extends age of onset in mice.
   Google Scholar
• Lachmann RH, te Vruchte D, Lloyd-Evans E et al.: Treatment with miglustat reverses the lipid-trafficking defect in Niemann–Pick disease type C. Neurobiol. Dis. 16, 654–658 (2004).
   Google Scholar
• Henderson LP, Lin L, Prasad A, Paul CA, Chang TY, Maue RA: Embryonic striatal neurons from Niemann–Pick type C mice exhibit defects in cholesterol metabolism and neurotrophin responsiveness. J. Biol. Chem. 275(26), 20179–20187 (2000).
   Google Scholar
• Griffin LD, Gong W, Verot L, Mellon SH: Niemann–Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone. Nat. Med. 10, 704–711 (2004).
   Google Scholar
• Neurosteroid supplementation from day 7 markedly alleviates disease symptoms in mice.
   Google Scholar
• Ory DS: Nuclear receptor signaling in the control of cholesterol homeostasis: have the orphans found a home? Circ. Res. 95, 660–670 (2004).
   Google Scholar
• Millat G, Bailo N, Molinero S, Rodriguez C, Chikh K, Vanier MT: Niemann–Pick C disease: use of denaturing high performance liquid chromatography for the detection of NPC1 and NPC2 genetic variations and impact on management of patients and families. Mol. Genet. Metab. 86, 220–232 (2005).
   Google Scholar
• Imrie J, Dasgupta S, Besley GT et al.: The natural history of Niemann–Pick disease type C in the UK. J. Inherit. Metab. Dis. 30(1), 51–59 (2006).
   Google Scholar
• Bauer P, Knoblich R, Bauer C et al.: NPC1: complete genomic sequence, mutation analysis, and characterization of haplotypes. Hum. Mutat. 19, 30–38 (2002).
   Google Scholar
• Reddy JV, Ganley IG, Pfeffer SR: Clues to neuro-degeneration in Niemann–Pick type C disease from global gene expression profiling. PLoS ONE 1, E19 (2006).
   Google Scholar
• Ganley IG, Pfeffer SR: Cholesterol accumulation sequesters Rab9 and disrupts late endosome function in NPC1-deficient cells. J. Biol. Chem. 281, 17890–17899 (2006).
   Google Scholar
• Bascunan-Castillo EC, Erickson RP, Howison CM et al.: Tamoxifen and vitamin E treatments delay symptoms in the mouse model of Niemann–Pick C. J. Appl. Genet. 45, 461–467 (2004).
   Google Scholar
• Langmade SJ, Gale SE, Frolov A et al.: Pregnane X receptor (PXR) activation: a mechanism for neuroprotection in a mouse model of Niemann–Pick C disease. Proc. Natl Acad. Sci. USA 103, 13807–13812 (2006).
   Google Scholar
• Davies JP, Ioannou YA: Topological analysis of Niemann–Pick C1 protein reveals that the membrane orientation of the putative sterol-sensing domain is identical to those of 3-hydroxy-3-methylglutaryl-CoA reductase and sterol regulatory element binding protein cleavage-activating protein. J. Biol. Chem. 275, 24367–24374 (2000).
   Google Scholar
• Hogue CW: Cn3D: a new generation of three-dimensional molecular structure viewer. Trends Biochem. Sci. 22, 314–316 (1997).
   Google Scholar